Tharimmune director files Form 3 with no holdings

Tharimmune, Inc. director William Thomas Wiley Jr. filed an initial ownership report stating that he beneficially owns no securities of the company as of the event date of January 30, 2026.

Accepted by SEC EDGAR 02/11/2026 - 05:16 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Tharimmune, Inc. director William Thomas Wiley Jr. filed an initial ownership report stating that he beneficially owns no securities of the company as of the event date of January 30, 2026. The filing lists no non-derivative or derivative holdings and reports no transactions.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Tharimmune (THAR) Form 3 filed by William Thomas Wiley Jr. show?

The Form 3 shows that director William Thomas Wiley Jr. reported no beneficial ownership of Tharimmune, Inc. securities. Both non-derivative and derivative tables are empty, and the explanation section explicitly states that no securities are beneficially owned.

Who is the reporting person on the Tharimmune (THAR) Form 3 filing?

The reporting person is William Thomas Wiley Jr., identified as a director of Tharimmune, Inc. The form confirms he is not an officer and not a 10% owner, and it is filed as a single reporting person Form 3.

Does the Tharimmune (THAR) Form 3 disclose any stock or option holdings?

No, the Form 3 discloses no stock or option holdings. Table I for non-derivative securities and Table II for derivative securities contain no positions, and the explanation of responses clearly states that no securities are beneficially owned.

What is the event date reported in the Tharimmune (THAR) Form 3?

The Form 3 lists an event date of January 30, 2026. This date marks when the reporting requirement was triggered, such as becoming a director, and the filing then documents that no Tharimmune securities were beneficially owned as of that date.

Is the Tharimmune (THAR) Form 3 filed by one or multiple reporting persons?

The Form 3 is filed by one reporting person. The checkbox section confirms that the report is for a single filer, covering only director William Thomas Wiley Jr., with no joint or group filing indicated in the document.

Does the Tharimmune (THAR) Form 3 report any recent insider transactions?

No, the Form 3 does not report any transactions. It is an initial statement of beneficial ownership, and all tables are effectively blank, with the narrative explicitly stating that no securities are beneficially owned by the director.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Wiley William Thomas Jr.

(Last) (First) (Middle)

33 FIFTH AVE. APT. 4A

(Street)

NEW YORK NY 10003

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
01/30/2026

3. Issuer Name and Ticker or Trading Symbol
Tharimmune, Inc. [ THAR ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ William T. Wiley, Jr.	02/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.